July 28, 2022
Researchers led by the University of Cincinnati's Agnes (Yu) Luo, PhD, have published findings in the journal Cell Reports showing a novel drug helped to repair the damage caused by ischemic stroke in animal models.
June 10, 2022
The University of Cincinnati's Pier Paolo Scaglioni, MD, has received a $1.5 million National Cancer Institute grant to continue research into the roles of the KRAS gene and lipids in lung cancer.
August 2, 2022
The University of Cincinnati's Jiajie Diao, PhD, and colleagues have published new research in the journal Nature Communications showing light-activated proteins can help normalize dysfunction within cells.
March 7, 2022
Researchers at the University of Cincinnati are expanding the Genetics of Unusual and Familial Movement Disorders study to include genetic testing for Chilean patients in search of a diagnosis for patients with rare movement disorders.
September 6, 2022
University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers published new findings on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments in the journal PLOS ONE.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
March 29, 2023
University of Cincinnati research on the steroid dexamethasone's effect on immune cells and benefit to severe COVID-19 patients was recently published in Frontiers in Immunology.
March 28, 2023
Treatment of the first patient in a clinical trial of FLASH proton therapy for cancers in the bones of the chest has been completed at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center.
April 3, 2023
University of Cincinnati researchers recently published findings in the journal Cancer that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.